199 related articles for article (PubMed ID: 33330444)
1. LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7
Cheng W; Shi X; Lin M; Yao Q; Ma J; Li J
Front Cell Dev Biol; 2020; 8():552822. PubMed ID: 33330444
[TBL] [Abstract][Full Text] [Related]
2. lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter.
Pu J; Wang J; Wei H; Lu T; Wu X; Wu Y; Shao Z; Luo C; Lu Y
Mol Ther Nucleic Acids; 2019 Dec; 18():351-362. PubMed ID: 31629962
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
Gong J; Ma L; Peng C; Liu J
Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MAGI2
Wei X; Hou Y; Zhang Y; Zhang H; Sun Z; Meng X; Wang Z
J Cancer; 2022; 13(1):343-353. PubMed ID: 34976194
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S
Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.
Yang Y; Yang H; Xu M; Zhang H; Sun M; Mu P; Dong T; Du S; Liu K
Hum Cell; 2018 Jul; 31(3):232-241. PubMed ID: 29679339
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D
J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MAGI2-AS3 overexpression had antitumor effect on Hepatic cancer via miRNA-23a-3p/PTEN axis.
Liu F; Deng W; Wan Z; Xu D; Chen J; Yang X; Xu J
Food Sci Nutr; 2021 May; 9(5):2517-2530. PubMed ID: 34026068
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
[TBL] [Abstract][Full Text] [Related]
12. MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.
Yang X; Wu S; Li X; Yin Y; Chen R
J Clin Lab Anal; 2020 Oct; 34(10):e23431. PubMed ID: 32533587
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
Wang G; Li H; Hou Y
Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H; Li Z; Tang Z; Li J; Lang X
J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
Hu R; Wu P; Liu J
Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells.
Cui S; Liu Z; Tang B; Wang Z; Li B
BMC Musculoskelet Disord; 2020 Mar; 21(1):149. PubMed ID: 32143617
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.
He J; Zhou X; Li L; Han Z
Cancer Manag Res; 2020; 12():289-302. PubMed ID: 32021443
[TBL] [Abstract][Full Text] [Related]
20. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
